Stage
Convertible Note | AliveAbout Rescue Therapeutics
Rescue Therapeutics (RTI) is commercializing RTI-97, a discovery by Texas A&M University researchers. When given as part of a cancer treatment regimen, RTI-79 shows the potential to increase the efficacy of chemotherapy drugs. The team has shown in vitro and in vivo that adding RTI-79 to doxorubicin materially improves doxorubicin's ability to kill ovarian and Non-Hodgkins lymphoma cancer cells - even cell lines known to be resistant to chemotherapy. The team has also shown that RTI-79 works with other chemotherapy agents such as velcade and cisplatinum. Further, the team has shown in vitro that RTI-79 works in treating drug-resistant cells from other cancer cell lines including breast, colon, pancreatic and prostate cancer.
Missing: Rescue Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Rescue Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Rescue Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Rescue Therapeutics is included in 2 Expert Collections, including Cancer.
Cancer
4,784 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Rescue Therapeutics Patents
Rescue Therapeutics has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/28/2017 | 1/24/2023 | Transcription factors, Clusters of differentiation, Human proteins, Proteins, Developmental biology | Grant |
Application Date | 6/28/2017 |
|---|---|
Grant Date | 1/24/2023 |
Title | |
Related Topics | Transcription factors, Clusters of differentiation, Human proteins, Proteins, Developmental biology |
Status | Grant |
Rescue Therapeutics Frequently Asked Questions (FAQ)
Where is Rescue Therapeutics's headquarters?
Rescue Therapeutics's headquarters is located at 3743 Carlon, Houston.
What is Rescue Therapeutics's latest funding round?
Rescue Therapeutics's latest funding round is Convertible Note.
Who are the investors of Rescue Therapeutics?
Investors of Rescue Therapeutics include Research Valley Innovation Center.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.